These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6809316)

  • 41. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate.
    Sage MR; Wilcox J; Evill CA; Benness GT
    Invest Radiol; 1982; 17(3):276-81. PubMed ID: 6811497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The blood-brain barrier disruption controversy: does it hold water?
    Ruffer JE; Glatstein E
    Cancer J Sci Am; 1998; 4(2):84-5. PubMed ID: 9532409
    [No Abstract]   [Full Text] [Related]  

  • 43. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Fortin D; Gendron C; Boudrias M; Garant MP
    Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
    Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
    Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.
    Neuwelt EA; Glasberg M; Frenkel E; Barnett P
    Ann Neurol; 1983 Sep; 14(3):316-24. PubMed ID: 6195955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors.
    Miyagami M; Tsubokawa T; Tazoe M; Kagawa Y
    Neurol Med Chir (Tokyo); 1990 Aug; 30(8):582-90. PubMed ID: 1703636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osmotic blood-brain barrier modification for the treatment of malignant brain tumors.
    Haluska M; Anthony ML
    Clin J Oncol Nurs; 2004 Jun; 8(3):263-7. PubMed ID: 15208820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors].
    Aronov MS; Kobiakov GL; Lubnin AIu; Iakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):52-9. PubMed ID: 19062597
    [No Abstract]   [Full Text] [Related]  

  • 49. Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
    Suda K; Nakasu S; Saito A
    Nihon Geka Hokan; 1985 Sep; 54(5):359-63. PubMed ID: 3938210
    [No Abstract]   [Full Text] [Related]  

  • 50. Blood-brain barrier disruption for the treatment of malignant brain tumors: The National Program.
    Doolittle ND; Petrillo A; Bell S; Cummings P; Eriksen S
    J Neurosci Nurs; 1998 Apr; 30(2):81-90. PubMed ID: 9642616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review.
    Elkassabany NM; Bhatia J; Deogaonkar A; Barnett GH; Lotto M; Maurtua M; Ebrahim Z; Schubert A; Ference S; Farag E
    J Neurosurg Anesthesiol; 2008 Jan; 20(1):45-8. PubMed ID: 18157025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
    Chakraborty S; Filippi CG; Wong T; Ray A; Fralin S; Tsiouris AJ; Praminick B; Demopoulos A; McCrea HJ; Bodhinayake I; Ortiz R; Langer DJ; Boockvar JA
    J Neurooncol; 2016 Jul; 128(3):405-15. PubMed ID: 26945581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
    Ohno K; Fredericks WR; Rapoport SI
    Surg Neurol; 1979 Oct; 12(4):323-8. PubMed ID: 524251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain.
    Neuwelt EA; Barnett PA; McCormick CI; Frenkel EP; Minna JD
    Neurosurgery; 1985 Sep; 17(3):419-23. PubMed ID: 3930991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification.
    Neuwelt EA; Barnett PA; Glasberg M; Frenkel EP
    Cancer Res; 1983 Nov; 43(11):5278-85. PubMed ID: 6193870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
    Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
    Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier.
    Millay RH; Klein ML; Shults WT; Dahlborg SA; Neuwelt EA
    Am J Ophthalmol; 1986 Nov; 102(5):626-32. PubMed ID: 3096140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
    Kozler P; Pokorný J
    Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.
    Dahlborg SA; Henner WD; Crossen JR; Tableman CM; Petrillo A; Braziel R; Neuwelt EA
    Cancer J Sci Am; 1996; 2(3):166-74. PubMed ID: 9166517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of intracarotid injection of methylprednisolone on cellular oedema after osmotic opening of the blood-brain barrier in rats.
    Kozler P; Pokorný J
    Prague Med Rep; 2004; 105(3):279-90. PubMed ID: 15782554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.